Earli
PrivateLast Round
Series B
Apr 23, 2026
Total Funding Raised
$128M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Earli is a biotechnology company that develops cancer-programmable genetic constructs that activate exclusively in cancer cells to produce synthetic biomarkers for early detection and personalized treatment of cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Medical Imaging
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Earli Comparables
Compare Earli with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Sunbird Bio | 81% | |
| Mercy BioAnalytics | 75% | |
| Harbinger Health | 75% | |
Earli Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 23, 2026 | ||||
| VC Round | Aug 15, 2025 | ||||
| Seed | Oct 15, 2024 | ||||
| Strategic | Aug 19, 2024 | ||||
| Series A | Jan 12, 2021 | ||||
Seed | Sep 1, 2018 |
Key People
Founding team and executive leadership
Earli Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Strategic, Series A, VC Round, Seed |
| Breyer Capital | Series A |
| Perceptive Advisors | Series A, Strategic, VC Round |
| Han River Partners | Strategic, VC Round |
| Khosla Ventures | Strategic, VC Round, Series A |
| ZhenFund | Seed |
| Zeev Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 48% MoM.
- Apr 23, 2026
$60M round completed.
Earli Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Earli's valuation, stock price, and market status.